Systemic Lupus Erythematosus Clinical Trials

Living with the Challenges of Lupus?

Explore Systemic Lupus Erythematosus Clinical Trials

Systemic lupus erythematosus (SLE) is a chronic autoimmune condition where the immune system mistakenly attacks healthy tissues, causing inflammation that can affect the skin, joints, kidneys, lungs, and other organs. Flare-ups are unpredictable, and symptoms often interfere with daily life.

Revive Research Institute is conducting systemic lupus erythematosus clinical trials to study investigational treatments for systemic lupus erythematosus. These studies focus on evaluating the safety and effectiveness of investigational therapies for individuals living with lupus.

To be eligible for SLE clinical trials in Michigan, participants must:

  • Be 18 to 70 years of age
  • Have been diagnosed with lupus (SLE) for at least 6 months

*Additional eligibility criteria may apply

*Participation in systemic lupus erythematosus clinical trials may provide access to expert medical care, regular health monitoring, and investigational therapies at no cost. Health insurance is not required to take part in these studies.

This field is for validation purposes and should be left unchanged.
Who is this information for?*(Required)

Please provide YOUR contact information only.

Name(Required)
Best Time to Call(Required)
User Agreement(Required)
For more info, please visit Privacy Policy.

About the Systemic Lupus Erythematosus Clinical Trial

Systemic lupus erythematosus (SLE) can cause fatigue, joint pain, skin rashes, and organ complications. Despite available treatments, many individuals continue to experience disease flare-ups or medication side effects.

Revive Research Institute is conducting a clinical study for systemic lupus erythematosus to evaluate an investigational treatment for systemic lupus erythematosus. This study aims to evaluate the safety and effectiveness of an investigational treatment for systemic lupus erythematosus.

Participants who meet eligibility requirements and qualify for enrollment will receive study-related care, lab assessments, and the investigational medication at no cost.

*All study procedures, doctor visits, and study-related medications are provided free of charge. Insurance is not required, and participants may receive reimbursement for time and travel.

*To take the next step, complete the form above, and a member of our clinical research team will contact you for a brief pre-screening. You’ll discuss your health history and learn if you qualify for the study.

Get Started: What to Expect?

If you qualify for a systemic lupus erythematosus clinical trial in Michigan, you may have the opportunity to participate in research evaluating an investigational treatment for lupus.

After submitting your information, our research team will contact you for a short pre-screening call. If you meet initial requirements, you will be invited to our research site for a screening visit, where we will review your medical history, perform physical exams, and run lab tests.

Those who qualify will review and sign an informed consent form (ICF), which explains the study procedures, potential risks, and potential benefits. Once enrolled, you will receive investigational treatment and ongoing care from our dedicated research staff.

Our team ensures every participant understands their role and feels supported throughout the study. By participating, you contribute to ongoing clinical research in systemic lupus erythematosus.

Age:

18 to 70 years of age

Condition:

Systemic Lupus Erythematosus (SLE)

Location

Michigan

Understanding Systemic Lupus Erythematosus

Common Symptoms Include:

  • Persistent fatigue and joint pain
  • Butterfly-shaped rash across the cheeks and nose
  • Muscle pain and swelling
  • Fever, photosensitivity, or mouth ulcers
  • Kidney or heart complications

Common Risk Factors:

  • Female
  • Family history of autoimmune diseases
  • Hormonal changes
  • Certain medications or infections

Currently, there is no cure for lupus, making systemic lupus erythematosus clinical trials vital for discovering safer and more effective therapies. Participating in systemic lupus erythematosus clinical trials Michigan helps accelerate progress toward better treatment and quality of life.

Frequently Asked Questions (FAQs)

It’s a chronic autoimmune disease that causes your immune system to attack healthy tissues, leading to inflammation and damage in different parts of the body.

SLE can cause irreversible organ damage, extreme fatigue, joint pain, and complications in the kidneys, heart, or lungs if not properly managed.

Current treatments include corticosteroids, immunosuppressants, and antimalarial drugs. However, they may not work for everyone, which is why systemic lupus erythematosus clinical trials are exploring better options.

By joining a clinical study for systemic lupus erythematosus, you can access investigational therapies at no cost, receive specialized care, and contribute to developing new systemic lupus erythematosus treatment options that could improve outcomes for future patients.